Literature DB >> 12776325

[Comprehensive utilization and development of traditional Tibetan medicine in China].

L Y Li1, B Z Ciren, D Zhan, Y F Wei.   

Abstract

OBJECTIVE: To deal with the further investigation field by discussing the status and present problem of traditional Tibetan medicine.
METHOD: Previous relevant investigations and literatures were summed up in the field. The present situation of traditional Tibetan medicine in China was analysed. RESULT: The textual research, basic medicinal property, exploration of developable medicinal resource and protection of endangered medicinal species etc. were elaborated and the key problem of further investigation in 21st century was expounded.
CONCLUSION: The textual research, basic medicinal property, exploration of develoable medicinal resources, especially monographic study on protection of major endangered medicinal resources should be intensified. Domestication and cultivation, and exploration of good-quality medicinal resources, quality evaluation and exploitation of effectual prescriptions are the focal field in the study of traditional Tibetan medicine.

Mesh:

Substances:

Year:  2001        PMID: 12776325

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  The Root Extract of Gentiana macrophylla Pall. Alleviates Cardiac Apoptosis in Lupus Prone Mice.

Authors:  Chih-Yang Huang; Tsai-Ching Hsu; Wei-Wen Kuo; Yi-Fan Liou; Shin-Da Lee; Da-Tong Ju; Chia-Hua Kuo; Bor-Show Tzang
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

2.  Targeted Separation of COX-2 Inhibitor from Pterocephalus hookeri Using Preparative High-Performance Liquid Chromatography Directed by the Affinity Solid-Phase Extraction HPLC System.

Authors:  Yunhe Zhu; Weidong Wang; Lei Jiang; Hui Tan; Zenggen Liu; Sirong Jiang; Yanduo Tao; Huaixiu Wen; Lijuan Mei
Journal:  Molecules       Date:  2021-12-06       Impact factor: 4.411

3.  New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics.

Authors:  Si-Yuan Pan; Shu-Feng Zhou; Si-Hua Gao; Zhi-Ling Yu; Shuo-Feng Zhang; Min-Ke Tang; Jian-Ning Sun; Dik-Lung Ma; Yi-Fan Han; Wang-Fun Fong; Kam-Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.